v3.25.2
Summary of Significant Accounting Policies (Tables)
3 Months Ended 12 Months Ended
Apr. 30, 2025
Jan. 31, 2025
Accounting Policies [Abstract]    
Schedule of Reconciliation of Weighted Average Shares Outstanding

A reconciliation of the weighted average shares outstanding used in basic and diluted earnings per share computation is as follows:

 

   2025   2024 
   For the Three Months Ended 
   April 30, 
   2025   2024 
Basic (loss) earnings per common share          
Numerator:          
Net income (loss) available to common shareholders  $(336,132)  $311,381 
Denominator:          
Weighted average common shares outstanding   56,779,658    49,867,529 
           
Basic earnings (loss) per common share  $(0.01)  $0.01 
Diluted earnings (loss) per common share          
Numerator:          
Net income (loss) available to common shareholders  $(336,132)  $311,381 
Remove convertible debt interest   -   (5,747)
Net income (loss) available to common shareholders  $(336,132)  $305,634 
Denominator:          
Weighted average common shares outstanding   56,779,658    49,867,529 
Dilutive effect of common stock warrants   -    2,103,986 
Dilutive effect of common stock options   -    734,760 
Adjusted weighted average common shares outstanding   56,779,658    52,706,275 
           
Diluted income (loss) per common share  $(0.01)  $0.01 

A reconciliation of the weighted average shares outstanding used in basic and diluted earnings per share computation is as follows:

 

   2025   2024 
   For the Years Ended 
   January 31, 
   2025   2024 
Basic (loss) earnings per common share          
Numerator:          
Net income (loss) available to common shareholders  $2,122,189   $(4,080,258)
Denominator:          
Weighted average common shares outstanding   50,647,226    31,012,343 
           
Basic earnings (loss) per common share  $0.04   $(0.13)
Diluted earnings per common share          
Numerator:          
Net income (loss) available to common shareholders  $2,122,189   $(4,080,258)
Remove derivative gain   (14,876)   - 
Remove convertible debt interest   (14,290)   - 
Net income (loss) available to common shareholders  $2,093,023   $(4,080,258)
Denominator:          
Weighted average common shares outstanding   50,647,226    31,012,343 
Dilutive effect of common stock warrants   10,427,644    - 
Dilutive effect of common stock options   1,555,436    - 
Adjusted weighted average common shares outstanding   62,630,306    31,012,343 
           
Diluted income (loss) per common share  $0.03   $(0.13)
Schedule of Fair Value of Financial Instruments

 

       Fair value measurements at reporting date using: 
Description  Fair Value   Quoted
prices in
active markets
for identical
liabilities
(Level 1)
   Significant
other
observable
inputs
(Level 2)
   Significant
unobservable
inputs
(Level 3)
 
Warrant and convertible note derivative liabilities at April 30, 2025  $264,843           $264,843 
Warrant and convertible note derivative liabilities at January 31, 2025  $311,338           $311,338